Tag: Sexually Transmitted Diseases: AIDS/HIV
May 2020 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for May 2020. This roundup includes...
HIV+ Men Are Not Receiving STD Testing, Prevention Services
Men receiving HIV care still not receiving guideline-recommended sexually transmitted disease testing
April 2020 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2020. This roundup includes...
Bundled Rapid HIV/Hep C Testing May Improve Infection Awareness
Bundled HIV, hepatitis C testing ups number of people with substance use disorders aware of infection status
Higher Alcohol Intake May Harm Bone Health in HIV Patients
Alcohol intake tied to levels of bone turnover markers in patients with HIV and substance use disorder
March 2020 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for March 2020. This roundup includes...
Fostemsavir Active in Multidrug-Resistant HIV-1 Infection
Reduction in HIV-1 RNA level significantly greater for fostemsavir versus placebo in randomized cohort
Second Case of HIV-1 Cure After Stem Cell Transplant Reported
HIV-1 viral load remained undetectable in plasma in patient up to 30 months after transplant
New HIV PrEP Drug Not Cost-Effective Compared With Generic
F/TAF would avert 2,101 fractures, 25 cases of end-stage renal disease, but not deemed cost-effective
Long-Acting Cabotegravir, Rilpivirine Noninferior in HIV-1
Studies demonstrate noninferiority to standard oral therapy, dolutegravir-abacavir-lamivudine
